表紙
市場調査レポート

MediPoint:スポーツ医学 - アジア太平洋地域市場の分析と予測

MediPoint: Sports Medicine - APAC Analysis and Market Forecasts

発行 GlobalData 商品コード 299753
出版日 ページ情報 英文 198 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
MediPoint:スポーツ医学 - アジア太平洋地域市場の分析と予測 MediPoint: Sports Medicine - APAC Analysis and Market Forecasts
出版日: 2014年03月31日 ページ情報: 英文 198 Pages
概要

整形外科インプラント市場が成熟化する中で、スポーツ医学は今後大きく成長する分野として世界各国で注目されています。日本は世界最大かつ最も成熟化した医療市場の一つですが、高齢者人口の増加と共に、股関節置換よりも費用の低い関節鏡視下手術の一大市場となっています。その他のアジア太平洋地域諸国(中国・インドなど)では、高齢層・若年層の双方とも大幅に増加しており、またより良い医療サービスを受ける機会が拡大しています。特にインドでは、若年層人口の増加に伴い、余暇活動に伴うスポーツ損傷の市場が拡大するものと思われます。

当レポートでは、アジア太平洋地域諸国におけるスポーツ医学市場(インプラント・関節鏡検査用装置を含む)について分析し、疾患の概要や市場構造、現在のアンメットニーズ、主な市場促進・抑制要因、今後の市場機会、現在治験中の主要製品、欧州諸国市場の動向(過去3年間の実績値と今後7年間の予測値)、製品カテゴリー別の詳細動向、主要企業のプロファイルなどを調査して、その結果を概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 臨床転帰

  • 保存療法
    • 患部固定と装具
    • 理学療法
    • 筋肉刺激
  • 薬物療法
    • 栄養補助剤
    • 鎮痛剤とNSAID(非ステロイド性抗炎症薬)
    • 副腎皮質ステロイド(コルチコステロイド)
    • 関節内補充療法
  • 軟組織の修復
  • 関節鏡検査
  • プレート・ねじ
  • 関節置換

第4章 産業の概要

  • 概要
  • 処置の傾向:アジア太平洋地域の場合
  • 市場アクセス:アジア太平洋地域の場合
  • 紛争とその解決(全4件)
  • 企業合併・買収(M&A)、パートナーシップ、その他の資本取引(全9件)
  • 経済的な影響
    • 先進国市場の場合
    • 新興国市場の場合

第5章 アンメットニーズ

  • 長期的な臨床データ
    • 股関節インプラントの関節鏡手術の場合
    • 回旋腱板損傷の場合
  • 軟骨・半月板修復用製品の開発
    • 半月板の治療
    • 股関節用の軟骨製品の開発
  • 早期治癒のための生物製剤
  • 機器の標準化と改善
    • 股関節・肩関節用の器具類
    • スクリュードライバーの標準化
  • 専門研修医向け訓練プログラム
  • 先進材料の研究
  • 生体吸収性技術の開発
  • 集中化
  • コスト抑制の必要性
  • 縫合糸アンカー製品の開発

第6章 市場機会の分析

  • 訓練プログラムの追加
  • 製品ラインの拡張
  • スポーツ医学分野での価格圧力の不在
  • 企業合併・買収(M&A)
  • スポーツ医学の季節性
  • 新興国市場
  • 低侵襲性手術に対する選好

第7章 市場促進・阻害要因と代替的要素

  • 市場促進要因:関連疾病の有病率の上昇
    • スポーツ関連の損傷
    • 老化
    • 外傷
  • 市場促進要因:股関節の関節鏡検査
    • 大腿寛骨臼インピンジメントの成長
    • 股関節関節鏡検査の専門医訓練プログラム
  • 市場促進要因:膝関節・肩関節の関節鏡検査
  • 市場促進要因:再置換手術
  • 市場促進要因:患者の要望と認知度
  • 市場促進要因:オーソバイオロジクスの発展
    • 骨移植片
    • 多血小板血漿
  • 市場促進要因:小規模企業における競争促進とイノベーション
  • 市場促進要因:材料の開発
    • 複合材料とバイオポリマー
    • 生体吸収性素材
    • 整形外科用の金属合金
  • 市場阻害要因:関節鏡検査の成果への疑問
    • 股関節の場合
    • 膝関節の場合
  • 市場阻害要因:急峻な学習曲線
  • 市場阻害要因:医療費償還
  • 市場阻害要因:規制強化による負荷
  • 市場阻害要因:効能の改善
  • 市場阻害要因:医療機器に対する物品税
  • 代替的要素:直視下手術 vs. 低侵襲性関節鏡手術
  • 代替的要素:保存療法のオプション

第8章 競合企業の評価

  • 概要
  • 上市済み製品(計8社分)

第9章 パイプライン評価

  • 概要
  • 製品プロファイル(計8製品)

第10章 注目すべき治験(計13件)

第11章 現在・将来の市場参入企業

  • 企業戦略の傾向
  • 企業プロファイル
    • Arthrex
    • ArthroCare Corporation
    • Biomet
    • ConMed Corporation
    • DePuy Companies
    • Smith & Nephew
    • Stryker
    • Tornier
    • Wright Medical Group
    • その他の企業

第12章 市場の将来展望

  • 各企業の市場シェア
    • 全世界
    • アジア太平洋地域
  • 分野別の市場見通し
    • 概要
    • 関節鏡検査用インプラント
    • 関節鏡検査用シェーバー
    • 関節鏡
    • 関節鏡検査用RF(高周波)ワンド
    • 関節鏡検査用可視化システム
    • 関節鏡検査用液体管理システム
  • 地域別の市場見通し
    • アジア太平洋地域
  • 第13章 付録

図表一覧

目次
Product Code: GDME1095CFR

This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compound annual growth rates (CAGR). GlobalData's analysis shows that while the orthopedics implant market is mature, sports medicine is an area with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to prove effectiveness of new techniques.

Japan is one of the largest healthcare markets in the world and has a mature healthcare market, similar to those of the west. With its high proportion of aging individuals, Japan is a prime market for arthroscopic treatment, which is cheaper than joint replacement. The other APAC markets, China and India, with their growing populations, consist of both elderly and young patients, who are increasingly able to afford better healthcare. India, in particular, has a booming young population that is expected to grow and see more recreation sporting injuries.

Scope

  • An overview of sports medicine, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized APAC sports medicine market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for sports medicine.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the sports medicine sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

  • Understand the trends shaping and driving the APAC sports medicine market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the APAC sports medicine market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the APAC sports medicine market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Clinical Outcomes

  • 3.1. Conservative Treatments
    • 3.1.1. Immobilization and Bracing
    • 3.1.2. Physical Therapy
    • 3.1.3. Muscle Stimulation
  • 3.2. Drug Therapy
    • 3.2.1. Nutritional Supplements
    • 3.2.2. Analgesics and NSAIDs
    • 3.2.3. Corticosteroids
    • 3.2.4. Viscosupplementation
  • 3.3. Soft Tissue Repair
  • 3.4. Arthroscopy
  • 3.5. Plates and Screws
  • 3.6. Joint Replacement

4. Industry Overview

  • 4.1. Overview
  • 4.2. Procedure Trends
    • 4.2.1. Asia-Pacific Region
  • 4.3. Market Access
    • 4.3.1. Asia-Pacific Region
  • 4.4. Disputes and Settlements
    • 4.4.1. Smith & Nephew Granted an Injunction Against Arthrex
    • 4.4.2. KFx Medical and Smith & Nephew Enter Into Licensing Agreement
    • 4.4.3. KFx Medical Wins Patent Infringement Lawsuit Against Arthrex
    • 4.4.4. ArthroCare and Smith & Nephew Settle Legal Disputes
  • 4.5. Mergers, Acquisitions, Partnerships, and Other Deals
    • 4.5.1. Stryker Acquires Pivot Medical
    • 4.5.2. Smith & Nephew Announces Acquisition of ArthroCare
    • 4.5.3. Smith & Nephew Acquires Plato Grup Assets
    • 4.5.4. Smith & Nephew Announces Acquisition of Its Brazil Distribution Business
    • 4.5.5. Kensey Nash Acquires Minority Stake in Orteq Sports Medicine
    • 4.5.6. Tornier Acquires C2M Medical
    • 4.5.7. Tornier Signs Licensing Agreement with T.A.G. Medical Products Corporation
    • 4.5.8. Biomet Acquires Cartilix
    • 4.5.9. Biomet Sports Medicine Enters Into Deal With Marc Tec
  • 4.6. Economic Impact
    • 4.6.1. Developed Countries
    • 4.6.2. Emerging Markets

5. Unmet Needs

  • 5.1. Long-Term Clinical Data
    • 5.1.1. Hip Arthroscopic Implants Clinical Data
    • 5.1.2. Rotator Cuff Injury Clinical Data
  • 5.2. Cartilage and Meniscal Repair Product Development
    • 5.2.1. Knee Meniscus Treatment
    • 5.2.2. Hip Cartilage Product Development
  • 5.3. Biologics for Faster Healing
  • 5.4. Standardization and Improvement of Instruments
    • 5.4.1. Hip and Shoulder Instrumentation
    • 5.4.2. Screwdriver Standardization
  • 5.5. Fellowship Training Programs
  • 5.6. Advanced Materials Research
  • 5.7. Bioabsorbable Technology Development
  • 5.8. Centralization
  • 5.9. Need for Cost-Containment
  • 5.10. Suture Anchor Product Development

6. Market Opportunity Analysis

  • 6.1. Adding More Training Programs
  • 6.2. Product Line Extensions
  • 6.3. Lack of Pricing Pressure in Sports Medicine
  • 6.4. Mergers and Acquisitions
  • 6.5. Seasonality of Sports Medicine
  • 6.6. Emerging Markets
  • 6.7. Minimally-Invasive Surgical Preference

7. Market Drivers, Barriers and Substitutes

  • 7.1. Driver: Rising Prevalence
    • 7.1.1. Sports-Related Injuries
    • 7.1.2. Aging
    • 7.1.3. Trauma
  • 7.2. Driver: Hip Arthroscopy
    • 7.2.1. Femoroacetabular Impingement Growth
    • 7.2.2. Hip Arthroscopy Fellowship Training Programs
  • 7.3. Driver: Knee and Shoulder Arthroscopy
  • 7.4. Driver: Revision Surgery
  • 7.5. Driver: Patient Demand and Awareness
  • 7.6. Driver: Orthobiologics Development
    • 7.6.1. Bone Grafts
    • 7.6.2. Platelet-Rich Plasma
  • 7.7. Driver: Rising Competition and Innovation Through Small Players
  • 7.8. Driver: Materials Development
    • 7.8.1. Composite Materials and Biopolymers
    • 7.8.2. Bioabsorbables
    • 7.8.3. Metallic Alloys in Orthopedics
  • 7.9. Barrier: Arthroscopy's Questionable Outcomes
    • 7.9.1. Hip Arthroscopy
    • 7.9.2. Knee Arthroscopy
  • 7.10. Barrier: Steep Learning Curve
  • 7.11. Barrier: Reimbursement
  • 7.12. Barrier: Burden of Rising Regulation
  • 7.13. Barrier: Proving Efficacy
  • 7.14. Barrier: Medical Device Excise Tax
  • 7.15. Substitute: Open Surgery Versus Minimally-Invasive Arthroscopy
  • 7.16. Substitute: Conservative Treatment Options

8. Competitive Assessment

  • 8.1. Overview
  • 8.2. Marketed Products in Sports Medicine
    • 8.2.1. Arthrex
    • 8.2.2. ArthroCare Corporation
    • 8.2.3. Biomet
    • 8.2.4. ConMed Corporation
    • 8.2.5. DePuy Mitek
    • 8.2.6. Smith & Nephew
    • 8.2.7. Stryker
    • 8.2.8. Tornier

9. Pipeline Assessment

  • 9.1. Overview
  • 9.2. Product Profiles
    • 9.2.1. Bioretec Drug-Releasing Screws
    • 9.2.2. Nanova Bioabsorbable Bone Screws
    • 9.2.3. MinInvasive Arthroscopic Suture Passer
    • 9.2.4. SpineSmith Pipeline
    • 9.2.5. DePuy Mitek FMS VUE
    • 9.2.6. Pivot Medical Hip Arthroscopy System
    • 9.2.7. University of Florida Shoulder Labral Anchor Delivery System
    • 9.2.8. University of California at San Diego Cartilage Regeneration Device

10. Clinical Trials to Watch

  • 10.1. Overview
  • 10.2. Can Shoulder Arthroscopy Work (CSAW) Study
  • 10.3. Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear
  • 10.4. Knee Arthroscopy Cohort Southern Denmark
  • 10.5. Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
  • 10.6. Femoroacetabular Impingement Randomized Controlled Trial
  • 10.7. Multicenter ACL Revision Study (MARS)
  • 10.8. Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability
  • 10.9. Microfracture in the Knee Study
  • 10.10. Single- Versus Double-Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears
  • 10.11. Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)
  • 10.12. Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty
  • 10.13. Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma
  • 10.14. Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews

11. Current and Future Players

  • 11.1. Trends in Corporate Strategy
  • 11.2. Company Profiles
    • 11.2.1. Arthrex
    • 11.2.2. ArthroCare Corporation
    • 11.2.3. Biomet
    • 11.2.4. ConMed Corporation
    • 11.2.5. DePuy Companies
    • 11.2.6. Smith & Nephew
    • 11.2.7. Stryker
    • 11.2.8. Tornier
    • 11.2.9. Wright Medical Group
    • 11.2.10. Other Key Players in Sports Medicine

12. Market Outlook

  • 12.1. Company Market Share
    • 12.1.1. Overview
    • 12.1.2. Asia-Pacific Market Share
  • 12.2. By Market Segment
    • 12.2.1. Overview
    • 12.2.2. Arthroscopy Implants
    • 12.2.3. Arthroscopic Shavers
    • 12.2.4. Arthroscopes
    • 12.2.5. Arthroscopic Radio Frequency Wands
    • 12.2.6. Arthroscopic Visualization Systems
    • 12.2.7. Arthroscopic Fluid Management Systems
  • 12.3. By Geography
    • 12.3.1. Asia-Pacific

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Research Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Secondary Research
  • 13.4. Physicians and Specialists Included in this Study
    • 13.4.1. Dr. Henry D.E. Atkinson
    • 13.4.2. Dr. Joshua Alpert
    • 13.4.3. Dr. Andrea Ferretti
    • 13.4.4. Dr. Alejandro Gonzalez Della Valle
    • 13.4.5. Dr. Andreas Imhoff
    • 13.4.6. Dr. Marcello Zaia Oliveira
    • 13.4.7. Dr. Vidhya Ravi
    • 13.4.8. Dr. Elvire Servien
    • 13.4.9. Dr. Yotaro Yamakado
  • 13.5. Primary Research
    • 13.5.1. Primary Research - Key Opinion Leader Interviews
    • 13.5.2. Primary Research - Physician and Industry Interviews
    • 13.5.3. Expert Panel Validation
  • 13.6. Forecasting Methodology
  • 13.7. About the Authors
    • 13.7.1. Analysts
    • 13.7.2. Global Head of Healthcare
  • 13.8. About MediPoint
  • 13.9. About GlobalData
  • 13.10. Disclaimer

List of Tables

  • Table 1: Most Common Soft Tissue Injuries to the Extremities in Sports Medicine
  • Table 2: APAC Region Arthroscopic Procedure Volumes, 2011-2020
  • Table 3: APAC Growth Rate for Arthroscopy by Joint and Country, 2013-2020
  • Table 4: Direct, Indirect, and Intangible Costs of Orthopedics
  • Table 5: Potential Market for Meniscus Treatment Types
  • Table 6: Metal Implant CharacteristicsThat Can Be Improved
  • Table 7: Arthrex Shoulder Implants
  • Table 8: Arthrex, Shoulder Instrumentation
  • Table 9: Arthrex, Knee Sutures and Suture Anchors
  • Table 10: Arthrex, Knee Graft Fixation Devices and Meniscal Products
  • Table 11: Arthrex, Hip Implants and Instruments
  • Table 12: Arthrex, Arthroscopy Procedure Capital Equipment
  • Table 13: Arthrex, Implants SWOT Analysis
  • Table 14: Arthrex, Instrumentation SWOT Analysis
  • Table 15: Arthrocare, Suture Implants
  • Table 16: ArthroCare, Suture Management Products
  • Table 17: ArthroCare, Cruciate Ligament Graft Fixation Products
  • Table 18: ArthroCare, Capital Equipment and Instruments
  • Table 19: ArthroCare, Implants SWOT Analysis
  • Table 20: Arthrocare, Instruments and Capital Equipment SWOT Analysis
  • Table 21: Biomet, Shoulder Arthroscopy Products
  • Table 22: Biomet, Knee Arthroscopy Products
  • Table 23: Biomet's Other Joints Arthroscopy Products
  • Table 24: Biomet, Capital Equipment Sports Medicine Products
  • Table 25: Biomet Implants SWOT Analysis
  • Table 26: Biomet, Capital Equipment SWOT Analysis
  • Table 27: ConMed, Shoulder Arthroscopy Products
  • Table 28: ConMed, Knee Arthroscopy Products
  • Table 29: ConMed, Small Joint and Hip Arthroscopy Products
  • Table 30: ConMed, Instruments and Capital Equipment
  • Table 31: ConMed, Implants SWOT Analysis
  • Table 32: ConMed, Capital Equipment SWOT Analysis
  • Table 33: DePuy Mitek, Fixation Devices
  • Table 34: DePuy, Mitek Instruments
  • Table 35: DePuy Mitek, Capital Equipment
  • Table 36: DePuy Mitek Implants, SWOT Analysis
  • Table 37: DePuy Mitek, Capital Equipment SWOT Analysis
  • Table 38: Smith & Nephew, Fixation Devices
  • Table 39: Smith & Nephew, Instruments and Capital Equipment
  • Table 40: Smith & Nephew Implants, SWOT Analysis
  • Table 41: Smith & Nephew, Capital Equipment SWOT Analysis
  • Table 42: Stryker, Fixation Devices
  • Table 43: Stryker, Instrumentation
  • Table 44: Stryker, Capital Equipment
  • Table 45: Stryker, Fixation Devices SWOT Analysis
  • Table 46: Stryker, Instrumentation and Capital Equipment SWOT Analysis
  • Table 47: Tornier Sports Medicine Products
  • Table 48: Tornier, Product Family SWOT Analysis
  • Table 49: Can Shoulder Arthroscopy Work (CSAW)
  • Table 50: Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear
  • Table 51: Knee Arthroscopy Cohort Southern Denmark
  • Table 52: Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
  • Table 53: Femoroacetabular Impingement Randomized Controlled Trial
  • Table 54: Multicenter ACL Revision Study (MARS)
  • Table 55: Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability
  • Table 56: Results at 10 to 14 Years After Microfracture in the Knee
  • Table 57: Single Versus Double Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears
  • Table 58: Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)
  • Table 59: Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty
  • Table 60: Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma in Large to Massive Tears
  • Table 61: Tibial Tunnel Widening in Anterior Cruciate Ligament Reconstruction Comparing Two Bioscrews
  • Table 62: Company Profile - Arthrex
  • Table 63: SWOT Analysis - Arthrex
  • Table 64: Company Profile - ArthroCare Corporation
  • Table 65: SWOT Analysis - ArthroCare Corporation
  • Table 66: Company Profile - Biomet
  • Table 67: SWOT Analysis - Biomet
  • Table 68: Company Profile - ConMed Corporation
  • Table 69: SWOT Analysis - ConMed Corporation
  • Table 70: Company Profile - DePuy Companies
  • Table 71: SWOT Analysis - DePuy Companies
  • Table 72: Company Profile - Smith & Nephew
  • Table 73: SWOT Analysis - Smith & Nephew
  • Table 74: Company Profile - Stryker
  • Table 75: SWOT Analysis - Stryker
  • Table 76: Company Profile - Tornier
  • Table 77: SWOT Analysis - Tornier
  • Table 78: Company Profile - Wright Medical Group
  • Table 79: SWOT Analysis - Wright Medical Group
  • Table 80: Other Sports Medicine Companies in the US Market
  • Table 81: Other Sports Medicine Companies in the EU Market
  • Table 82: Other Sports Medicine Companies in the APAC Market
  • Table 83: APAC Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 84: APAC Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011-2020
  • Table 85: APAC Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011-2020
  • Table 86: APAC Sports Medicine Sales Forecast ($m), Arthroscopes, 2011-2020
  • Table 87: APAC Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011-2020
  • Table 88: APAC Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011-2020
  • Table 89: APAC Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011-2020
  • Table 90: APAC Sports Medicine Implant and Capital Equipment Sales ($m) Forecast by Country, 2011-2020
  • Table 91: Japan Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 92: China Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 93: India Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 94: Primary Research Interviews Completed in Sports Medicine

List of Figures

  • Figure 1: APAC Region Arthroscopic Procedure Volumes, 2011-2020
  • Figure 2: Sources of Orthopedic Trauma (%) (n=103)
  • Figure 3: Japan Market Share for Arthroscopy, 2012
  • Figure 4: China Market Share for Arthroscopy, 2012
  • Figure 5: India Market Share for Arthroscopy, 2012
  • Figure 6: APAC Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 7: APAC Sports Medicine Sales Forecast ($m), Arthroscopy Implants, 2011-2020
  • Figure 8: APAC Sports Medicine Sales Forecast ($m), Arthroscopic Shavers, 2011-2020
  • Figure 9: APAC Sports Medicine Sales Forecast ($m), Arthroscopes, 2011-2020
  • Figure 10: APAC Sports Medicine Sales Forecast ($m), Arthroscopic RF Wands, 2011-2020
  • Figure 11: APAC Sports Medicine Sales Forecast ($m), Arthroscopic Visualization Systems, 2011-2020
  • Figure 12: APAC Sports Medicine Sales Forecast ($m), Arthroscopic Fluid Management Systems, 2011-2020
  • Figure 13: Japan Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 14: China Sports Medicine Sales Forecast ($m), 2011-2020
  • Figure 15: India Sports Medicine Sales Forecast ($m), 2011-2020
Back to Top